Deletion of both Perk alleles effectively inhibited BrafV600E-dependent melanoma in the setting of Fbxo4-deficiency, while deletion of one allele of Perk (Perk+/-) was not sufficient to either inhibit or accelerate melanoma genesis (Fig 5A; S4A Fig). This evidence concerns the gene EIF2AK3 and melanoma.